Aurora Spine Corporation

Informe acción TSXV:ASG

Capitalización de mercado: CA$34.5m

Aurora Spine Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Aurora Spine han disminuido a una tasa media anual de -8%, mientras que en la industria Medical Equipment los beneficios crecieron en un 12% anualmente. Los ingresos han ido creciendo a una tasa media de 12.2% al año.

Información clave

-8.0%

Tasa de crecimiento de los beneficios

1.0%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment -19.2%
Tasa de crecimiento de los ingresos12.2%
Rentabilidad financiera-12.7%
Margen neto-3.8%
Última actualización de beneficios30 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Aurora Spine Corporation (CVE:ASG) Soars 26% But It's A Story Of Risk Vs Reward

Oct 19
Aurora Spine Corporation (CVE:ASG) Soars 26% But It's A Story Of Risk Vs Reward

We Think Aurora Spine (CVE:ASG) Has A Fair Chunk Of Debt

Oct 16
We Think Aurora Spine (CVE:ASG) Has A Fair Chunk Of Debt

Aurora Spine Corporation's (CVE:ASG) Subdued P/S Might Signal An Opportunity

Aug 14
Aurora Spine Corporation's (CVE:ASG) Subdued P/S Might Signal An Opportunity

We Think Shareholders May Want To Consider A Review Of Aurora Spine Corporation's (CVE:ASG) CEO Compensation Package

Jun 19
We Think Shareholders May Want To Consider A Review Of Aurora Spine Corporation's (CVE:ASG) CEO Compensation Package

Is Aurora Spine (CVE:ASG) A Risky Investment?

May 29
Is Aurora Spine (CVE:ASG) A Risky Investment?

There Is A Reason Aurora Spine Corporation's (CVE:ASG) Price Is Undemanding

Mar 19
There Is A Reason Aurora Spine Corporation's (CVE:ASG) Price Is Undemanding

Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?

Oct 15
Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?

Why Investors Shouldn't Be Surprised By Aurora Spine Corporation's (CVE:ASG) Low P/S

Aug 11
Why Investors Shouldn't Be Surprised By Aurora Spine Corporation's (CVE:ASG) Low P/S

Here's Why Aurora Spine (CVE:ASG) Can Afford Some Debt

May 01
Here's Why Aurora Spine (CVE:ASG) Can Afford Some Debt

Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt

Dec 22
Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt

Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?

Aug 23
Would Aurora Spine (CVE:ASG) Be Better Off With Less Debt?

Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?

May 04
Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?

Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?

Dec 23
Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?

Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt

Jun 11
Aurora Spine (CVE:ASG) Is Making Moderate Use Of Debt

A Look At The Intrinsic Value Of Aurora Spine Corporation (CVE:ASG)

Feb 26
A Look At The Intrinsic Value Of Aurora Spine Corporation (CVE:ASG)

Is Aurora Spine (CVE:ASG) A Risky Investment?

Nov 19
Is Aurora Spine (CVE:ASG) A Risky Investment?

Desglose de ingresos y gastos

Cómo gana y gasta dinero Aurora Spine. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

TSXV:ASG Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 2417-191
30 Jun 2416-181
31 Mar 2416-181
31 Dec 2315-281
30 Sep 2314-271
30 Jun 2314-271
31 Mar 2314-271
31 Dec 2215-271
30 Sep 2214-271
30 Jun 2213-271
31 Mar 2212-261
31 Dec 2111-261
30 Sep 2110-151
30 Jun 219-151
31 Mar 219040
31 Dec 209040
30 Sep 209-140
30 Jun 209-240
31 Mar 2011-240
31 Dec 1911-140
30 Sep 1911-140
30 Jun 1911040
31 Mar 1910040
31 Dec 189040
30 Sep 188-140
30 Jun 187-130
31 Mar 186-240
31 Dec 176-240
30 Sep 176-240
30 Jun 176-240
31 Mar 177-240
31 Dec 167-240
30 Sep 167-240
30 Jun 166-240
31 Mar 165-240
31 Dec 155-350
30 Sep 155-570
30 Jun 154-680
31 Mar 154-890
31 Dec 143-880
30 Sep 141-670
30 Jun 141-550
31 Mar 140-440
31 Dec 130-330

Ingresos de calidad: ASG actualmente no es rentable.

Margen de beneficios creciente: ASG actualmente no es rentable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: ASG no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 8% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ASG en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: ASG no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Medical Equipment (10.4%).


Rentabilidad financiera

Alta ROE: ASG tiene una rentabilidad financiera negativa (-12.65%), ya que actualmente no es rentable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado